RSS   Newsletter   Contact   Advertise with us
Post Online Media

Ligand Pharmaceuticals appoints Nancy Ryan Gray to board

Nancy Ryan GrayLigand Pharmaceuticals Incorporated, a biotech company, announced the appointment of Nancy Ryan Gray to the company’s board of directors.

Dr. Gray currently serves as President and Chief Executive Officer of Gordon Research Conferences.

Prior to joining Gordon Research Conferences in 2003, for nine years Dr. Gray was with the American Chemical Society (ACS) in Washington, D.C., the world’s largest scientific society, most recently as Director of Membership.

Dr. Gray also was the liaison to the Board Committee on Grants and Awards and the Council Committee on Nominations and Elections, and was responsible for the ACS national election process.

Prior to joining the ACS, she spent nine years as a Senior Research Scientist at Exxon/Mobil Research and Engineering (formerly Exxon Production Research) in Houston.

Dr. Gray is a Fellow of the Royal Society of Chemistry, a Fellow of the American Association for the Advancement of Science and a member of the American Chemical Society.

She received a B.S. in chemistry from the University of Notre Dame and a Ph.D. in Fuel Chemistry from The Pennsylvania State University.

Dr. Gray was a Research Fellow at the Foundation on Matter Institute for Atomic and Molecular Physics in Amsterdam, and completed the Harvard Executive Education Finance for Senior Executives program. She also has authored or co-authored numerous scientific articles.


 LATEST MOVES FROM California 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy